Gastrointestinal Drugs Global Market Report 2022

Mar 2022| TBR329F| TBRC (Publisher)

Report Highlights

Including: 1) By Type: Pharmaceutical Drugs; Biologics
2) By Drug Type: Antacids; Antiulcerants; Antiobesity; Antiemetics And Antinauseants; Antidiarrhoeals
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
4) By Route Of Administration: Oral; Parenteral; Others
5) By Drug Classification: Branded Drugs; Generic Drugs
6) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
Covering: Takeda Pharmaceuticals; Bayer AG; Abbott Laboratories; Otsuka Holdings Co. ltd.; Johnson & Johnson; Reckitt Benckiser Group plc.

Gastrointestinal Drugs Global Market Report 2022 from The Business Research Company covers this critical market and the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for gastrointestinal drugs. Vitamins and Minerals play a crucial role in the treatment of pateints with Covid 19 as they are used as immunity boosters.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the gastrointestinal drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Gastrointestinal Drugs Market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider gastrointestinal drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The gastrointestinal drugs market section of the report gives context. It compares the gastrointestinal drugs market with other segments of the gastrointestinal drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, gastrointestinal drugs indicators comparison.

 

 

Scope

Markets Covered:

  • By Type: Pharmaceutical Drugs; Biologics
  • By Drug Type: Antacids; Antiulcerants; Antiobesity; Antiemetics And Antinauseants; Antidiarrhoeals
  • By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
  • By Route Of Administration: Oral; Parenteral; Others
  • By Drug Classification: Branded Drugs; Generic Drugs
  • By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Takeda Pharmaceuticals; Bayer AG; Abbott Laboratories; Otsuka Holdings Co. ltd.; Johnson & Johnson

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, gastrointestinal drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Historic Market Growth, Value ($ Billion)
  • Table 2 : Forecast Market Growth, Value ($ Billion)
  • Table 3 : Global Gastrointestinal Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 4 : Global Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 5 : Global Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6 : Global Gastrointestinal Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7 : Global Gastrointestinal Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8 : Global Gastrointestinal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9 : Global Gastrointestinal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10 : Global Gastrointestinal Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11 : Global Gastrointestinal Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12 : Gastrointestinal Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Table 13 : Per Capita Average Gastrointestinal Drugs Market Expenditure, 2016-2026, Global
  • Table 14 : Asia-Pacific, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 15 : Asia-Pacific, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 16 : Asia-Pacific, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 17 : Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Table 18 : Asia-Pacific Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 19 : China Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 20 : China Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 21 : Australia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 22 : Australia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 23 : Hong Kong Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 24 : India Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 25 : India Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 26 : Indonesia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 27 : Indonesia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 28 : Japan Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 29 : Japan Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 30 : Malaysia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 31 : New Zealand Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 32 : Philippines Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 33 : Singapore Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 34 : South Korea Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 35 : Thailand Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 36 : Vietnam Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 37 : Western Europe, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 38 : Western Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 39 : Western Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 40 : Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Western Europe Countries
  • Table 41 : Western Europe Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 42 : Austria Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 43 : Belgium Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 44 : Denmark Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 45 : Finland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 46 : France Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 47 : France Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 48 : Germany Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 49 : Germany Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 50 : Ireland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 51 : Italy Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 52 : Netherlands Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 53 : Norway Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 54 : Portugal Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 55 : Spain Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 56 : Sweden Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 57 : Switzerland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 58 : UK Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 59 : UK Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 60 : Eastern Europe, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 61 : Eastern Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 62 : Eastern Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 63 : Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Table 64 : Eastern Europe Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 65 : Czech Republic Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 66 : Poland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 67 : Romania Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 68 : Russia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 69 : Russia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 70 : North America, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 71 : North America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 72 : North America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 73 : Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, North America Countries
  • Table 74 : North America Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 75 : Canada Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 76 : Mexico Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 77 : USA Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 78 : USA Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 79 : South America, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 80 : South America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 81 : South America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 82 : Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, South America Countries
  • Table 83 : South America Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 84 : Argentina Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 85 : Brazil Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 86 : Brazil Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 87 : Chile Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 88 : Colombia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 89 : Peru Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 90 : Venezuela Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 91 : Middle East, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 92 : Middle East, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 93 : Middle East, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 94 : Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Middle East Countries
  • Table 95 : Middle East Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 96 : Saudi Arabia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 97 : Israel Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 98 : Turkey Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 99 : UAE Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 100 : Africa, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 101 : Africa, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 102 : Africa, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 103 : Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Africa Countries
  • Table 104 : Africa Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 105 : Egypt Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 106 : Nigeria Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 107 : South Africa Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 108 : Takeda Pharmaceticals Financial Performance
  • Table 109 : Bayer AG Financial Performance
  • Table 110 : Abbott Laboratories Financial Performance
  • Table 111 : Otsuka Holdings Co ltd Financial Performance
  • Table 112 : Johnson & Johnson Financial Performance
  • Table 113 : Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Table 114 : Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 115 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 116 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Table 117 : Global Gastrointestinal Drugs Market In 2026- Growth Countries
  • Table 118 : Global Gastrointestinal Drugs Market In 2026- Growth Segments
  • Table 119 : Global Gastrointestinal Drugs Market In 2026- Growth Strategies
  • Figure 1 : Historic Market Growth, Value ($ Billion)
  • Figure 2 : Forecast Market Growth, Value ($ Billion)
  • Figure 3 : Global Gastrointestinal Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 4 : Global Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 5 : Global Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6 : Global Gastrointestinal Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7 : Global Gastrointestinal Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8 : Global Gastrointestinal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9 : Global Gastrointestinal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10 : Global Gastrointestinal Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11 : Global Gastrointestinal Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12 : Gastrointestinal Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Figure 13 : Per Capita Average Gastrointestinal Drugs Market Expenditure, 2016-2026, Global
  • Figure 14 : Asia-Pacific, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 15 : Asia-Pacific, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 16 : Asia-Pacific, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 17 : Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Figure 18 : Asia-Pacific Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 19 : China Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 20 : China Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 21 : Australia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 22 : Australia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 23 : Hong Kong Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 24 : India Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 25 : India Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 26 : Indonesia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 27 : Indonesia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 28 : Japan Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 29 : Japan Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 30 : Malaysia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 31 : New Zealand Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 32 : Philippines Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 33 : Singapore Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 34 : South Korea Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 35 : Thailand Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 36 : Vietnam Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 37 : Western Europe, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 38 : Western Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 39 : Western Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 40 : Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Western Europe Countries
  • Figure 41 : Western Europe Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 42 : Austria Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 43 : Belgium Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 44 : Denmark Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 45 : Finland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 46 : France Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 47 : France Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 48 : Germany Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 49 : Germany Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 50 : Ireland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 51 : Italy Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 52 : Netherlands Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 53 : Norway Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 54 : Portugal Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 55 : Spain Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 56 : Sweden Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 57 : Switzerland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 58 : UK Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 59 : UK Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 60 : Eastern Europe, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 61 : Eastern Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 62 : Eastern Europe, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 63 : Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Figure 64 : Eastern Europe Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 65 : Czech Republic Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 66 : Poland Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 67 : Romania Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 68 : Russia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 69 : Russia Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 70 : North America, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 71 : North America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 72 : North America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 73 : Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, North America Countries
  • Figure 74 : North America Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 75 : Canada Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 76 : Mexico Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 77 : USA Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 78 : USA Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 79 : South America, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 80 : South America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 81 : South America, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 82 : Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, South America Countries
  • Figure 83 : South America Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 84 : Argentina Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 85 : Brazil Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 86 : Brazil Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 87 : Chile Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 88 : Colombia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 89 : Peru Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 90 : Venezuela Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 91 : Middle East, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 92 : Middle East, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 93 : Middle East, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 94 : Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Middle East Countries
  • Figure 95 : Middle East Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 96 : Saudi Arabia Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 97 : Israel Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 98 : Turkey Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 99 : UAE Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 100 : Africa, Gastrointestinal Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 101 : Africa, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 102 : Africa, Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 103 : Per Capita Average Gastrointestinal Drugs Expenditure, 2016-2026, Africa Countries
  • Figure 104 : Africa Gastrointestinal Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 105 : Egypt Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 106 : Nigeria Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 107 : South Africa Gastrointestinal Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 108 : Takeda Pharmaceticals Financial Performance
  • Figure 109 : Bayer AG Financial Performance
  • Figure 110 : Abbott Laboratories Financial Performance
  • Figure 111 : Otsuka Holdings Co ltd Financial Performance
  • Figure 112 : Johnson & Johnson Financial Performance
  • Figure 113 : Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Figure 114 : Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 115 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 116 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Figure 117 : Global Gastrointestinal Drugs Market In 2026- Growth Countries
  • Figure 118 : Global Gastrointestinal Drugs Market In 2026- Growth Segments
  • Figure 119 : Global Gastrointestinal Drugs Market In 2026- Growth Strategies

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Gastrointestinal Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change

  • Date - Feb 2022
  • Code - TBR329E

Including: 1) By Type: Antacids; Antiulcerants; Antiemetics And Antinauseants; Antidiarrheals; Others
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Drugs; Over-The-Counter Drugs
Covering: Takeda Pharmaceutical; AbbVie; Johnson & Johnson; Bausch Health; AstraZeneca Plc; Sanofi; Bayer AG; ...

Gastrointestinal Drugs Global Market Report 2021: COVID 19 Implications and Growth to 2030

  • Date - Feb 2021
  • Code - TBR329D

Including: 1) By Type: Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity; Antiemetics And Antinauseants; Antidiarrhoeals
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Covering: Takeda Pharmaceticals; Allergan Plc; Novo ...

Gastrointestinal Drugs Global Market Strategic Briefing 2020: Covid 19 Impact and Recovery

  • Date - Jun 2020
  • Code - TBR329C

Including: Antiulcerants; Vitamin And Minerals; Antacids; Antiemetics And Antinauseants; Antiobesity; Antidiarrhoeals

The global gastrointestinal drugs market is expected to decline from $40.2 billion in 2019 to $37.9 billion in 2020 at a CAGR of -5.75%, this is due to disruption in supply chains and restrictions on trade of pharmaceutical ingredients and products across countries owing to the COVID-19 outbreak.. The ...

Gastrointestinal Drugs Global Market Report 2020-30: Covid 19 Implications and Growth

  • Date - May 2020
  • Code - TBR329B

Including: 1) By Type: Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity; Antiemetics And Antinauseants; Antidiarrhoeals
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Covering: Takeda Pharmaceticals; Allergan Plc; Novo Nordisk A/S; AstraZeneca Plc; ...

Gastrointestinal Drugs Global Market Report 2019

  • Date - Jan 2019
  • Code - TBR329A

Including: Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals

Covering: Takeda Pharmaceticals, Allergan Plc, Novo Nordisk A/S, AstraZeneca Plc, Johnson & Johnson

The Business Research Company
Price: $5000

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS